Furthermore, we proved that shRNA knockdown of SND1 not only reduced the T-Smad2, P-Smad2, Smad4 and MMP2 in GBM cells, but also eliminated the positive regulatory effects of TGFβ1 on these proteins and SND1. This evidence concerns the gene SMAD2 and glioblastoma.